CCL17



CCL17

A1AA1R2RR2G3GG3T4TT4N5NN5V6VV6G7GG7R8RR8E9EE9C10CC10C11CC11L12LL12E13EE13Y14YY14F15FF15K16KK16G17GG17A18AA18I19II19P20PP20L21LL21R22RR22K23KK23L24LL24K25KK25T26TT26W27WW27Y28YY28Q29QQ29T30TT30S31SS31E32EE32D33DD33C34CC34S35SS35R36RR36D37DD37A38AA38I39II39V40VV40F41FF41V42VV42T43TT43V44VV44Q45QQ45G46GG46R47RR47... and 24 more residue(s)...... and 24 more residue(s)

SMILES None
InChIKey None
Sequence ARGTNVGRECCLEYFKGAIPLRKLKTWYQTSEDCSRDAIVFVTVQGRAICSDPNNKRVKNAVKYLQSLERS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL17

A1AA1R2RR2G3GG3T4TT4N5NN5V6VV6G7GG7R8RR8E9EE9C10CC10C11CC11L12LL12E13EE13Y14YY14F15FF15K16KK16G17GG17A18AA18I19II19P20PP20L21LL21R22RR22K23KK23L24LL24K25KK25T26TT26W27WW27Y28YY28Q29QQ29T30TT30S31SS31E32EE32D33DD33C34CC34S35SS35R36RR36D37DD37A38AA38I39II39V40VV40F41FF41V42VV42T43TT43V44VV44Q45QQ45G46GG46R47RR47... and 24 more residue(s)...... and 24 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.